MoxDuo IR morphine/oxycodone regulatory update

By WIR Staff | Jun 2, 2014 | 7:00 AM GMT

FDA issued a complete response letter to QRxPharma for MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The

Read the full 203 word article

How to gain access

Continue reading with a
two-week free trial.